Guardant Health
GH
#3091
Rank
A$6.20 B
Marketcap
$50.20
Share price
5.39%
Change (1 day)
36.14%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2023 (TTM): -$7.37

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -$7.55. In 2022 the company made an earnings per share (EPS) of -$9.84 a decrease over its 2021 EPS that were of -$6.15.

EPS history for Guardant Health from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$7.37-25.09%
2022-$9.8460%
2021-$6.1555.04%
2020-$3.97207.14%
2019-$1.29-19.81%
2018-$1.61

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$7.41-1.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.18-97.57%๐Ÿ‡บ๐Ÿ‡ธ USA